Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg
#Johnson & Johnson #DePuy Synthes #orthopedics unit #sale #$20 billion #private equity #hip and knee replacements #Bloomberg #corporate restructuring #medical devices #February 19 2026
📌 Key Takeaways
- Johnson & Johnson plans to sell its DePuy Synthes orthopedics unit for over $20 billion.
- The unit specializes in hip and knee replacement devices and generated $9.3 billion in sales last year.
- J&J is preparing documentation and financial information for the sale before meeting with potential buyers in the coming weeks.
- Private equity firms and competing medical device companies are reportedly interested in forming acquisition teams.
- The sale represents a shift from J&J’s earlier announcement to separate the unit to now pursuing an outright sale.
- Bloomberg reported the information citing sources familiar with the matter on February 19 2026.
📖 Full Retelling
Johnson & Johnson is preparing to sell its orthopedics unit, DePuy Synthes, in the United States for more than $20 billion, as reported by Bloomberg on February 19 2026, in order to streamline its portfolio and attract strategic buyers. The company is compiling documentation and financial details for the unit before meetings with potential purchasers, and the move could open the door for private equity firms and competing medical device companies to acquire the business that generated $9.3 billion in sales last year. Analysts say the sale aligns with J&J’s broader strategy to focus on its core pharmaceutical and consumer health segments while unlocking value from its specialty device holdings.
🏷️ Themes
Corporate finance and restructuring, Healthcare and medical devices, Mergers and acquisitions, Private equity investment, Strategic divestitures
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold largely flat as investors weigh geopolitical tensions, hawkish Fed minutes US said ready to begin war with Iran; Trump warns ’bad things will happen’ Morgan Stanley identifies best gas stocks amid AI data center boom Hawkish hints in Fed minutes; Walmart to report - what’s moving markets (South Africa Philippines Nigeria) Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg By Investing.com Editor Louis Juricic Stock Markets Editor Louis Juricic Published 02/19/2026, 02:26 PM Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg 0 JNJ 0.48% Investing.com -- Johnson & Johnson is getting ready to sell its orthopedics unit, DePuy Synthes, which could be valued at more than $20 billion, according to a report from Bloomberg News, citing people familiar with the matter. The company is currently preparing documents and financial information for the unit before meeting with potential buyers in the coming weeks, these sources said. Several large private equity firms are considering forming teams to potentially acquire the business, which specializes in devices used in hip and knee replacements. The unit generated $9.3 billion in sales last year. Besides private equity interest, the DePuy Synthes business could also attract attention from competing medical device companies, according to the sources. J&J had previously announced plans to separate the orthopedics unit, but is now exploring an outright sale option. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read full article at source